Connect Biopharma Holdings Limited · NASDAQ:CNTB

Xanthopoulos Kleanthis Gabriel received 2,816 Connect Biopharma Holdings Limited shares as an award (Form 4)

Traded Mar 31, 2026 · Filed Apr 2, 2026

On Mar 31, 2026, Xanthopoulos Kleanthis Gabriel (Director) received 2,816 Connect Biopharma Holdings Limited shares as an award, leaving 82,816 shares. Filed Apr 2, 2026 (Form 4).

Awarded
2,816 shares
Holding after
82,816 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Mar 31, 2026Ordinary SharesAward2,81682,816Direct

Source

View original at SEC

Related